RMTI

Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Reports First Quarter Results

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Corey Williams — May 10, 2016, 4:55 PM EDT

Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Provides Update on Preparations for Calcitriol Commercial Launch

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Corey Williams — May 4, 2016, 8:47 AM EDT

Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Announces Triferic Presentation at the National Kidney Foundation Spring Clinical Meeting

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Corey Williams — April 28, 2016, 8:17 AM EDT

Stock Update (NASDAQ:RMTI): U.S. FDA Approves Rockwell Medical Inc’s Triferic Powder Packet for Treating Anemia in Hemodialysis Patients

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Corey Williams — April 26, 2016, 8:13 AM EDT

Stock Update (NASDAQ:RMTI): China FDA Accepts Rockwell Medical Inc’s Triferic® Drug Submission for Commercialization in China

Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Corey Williams — March 21, 2016, 8:14 AM EDT

Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Reports Fourth Quarter and Fiscal 2015 Results

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Corey Williams — February 29, 2016, 7:16 PM EDT

Company Update (NASDAQ:RMTI): Rockwell Medical Inc Files IND to Investigate Triferic for Rare Orphan Disease Iron-Refractory, Iron-Deficiency Anemia

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Corey Williams — February 22, 2016, 8:08 AM EDT

Company Update (NASDAQ:RMTI): Rockwell Medical Inc Enters Into Exclusive License Agreement With Wanbang to Commercialize Triferic® in China

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Corey Williams — February 16, 2016, 8:54 AM EDT

Stock Update (NASDAQ:RMTI): Rockwell Medical Inc Announces Two Triferic® Poster Presentations Accepted for Presentation at National Kidney Foundation Spring Clinical Meetings

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for …

Corey Williams — January 19, 2016, 10:17 AM EDT

Stock Update (NASDAQ:RMTI): Rockwell Medical Inc’s Triferic Receives Permanent J-Code for Renal Drug Reimbursement

Rockwell Medical Inc (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services …

Corey Williams — November 30, 2015, 8:27 AM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts